tranylcypromine has been researched along with Anemia, Cooley's in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Engel, JD; Shi, L; Tanabe, O | 1 |
| Fisher, CA; Gibbons, RJ; Higgs, DR; Mettananda, S; Oppermann, U; Sloane-Stanley, JA; Taylor, S | 1 |
2 other study(ies) available for tranylcypromine and Anemia, Cooley's
| Article | Year |
|---|---|
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
Topics: Anemia, Sickle Cell; Animals; beta-Globins; beta-Thalassemia; Cell Differentiation; Cells, Cultured; Erythroid Cells; Fetal Hemoglobin; gamma-Globins; Histone Demethylases; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Monoamine Oxidase Inhibitors; Nuclear Receptor Subfamily 2, Group C, Member 1; Promoter Regions, Genetic; Receptors, Steroid; Receptors, Thyroid Hormone; RNA Interference; RNA, Small Interfering; Tranylcypromine | 2013 |
Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
Topics: alpha-Globins; Antigens, CD34; beta-Thalassemia; Butyric Acid; Cell Culture Techniques; Enzyme Inhibitors; Erythroid Cells; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Hydroxyquinolines; Hydroxyurea; Molecular Sequence Annotation; Piperazines; RNA, Small Interfering; Small Molecule Libraries; Tranylcypromine; Vorinostat | 2017 |